RAYONIER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
257
RAYONIER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Rayonier Advanced Materials, Inc. - (RYAM)

NEW ORLEANS, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 16, 2017 to file lead plaintiff applications in a securities class action lawsuit against Rayonier Advanced Materials, Inc. (NYSE: RYAM ), if they purchased the Company’s shares between October 29, 2014 and August 19, 2015, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Middle District of Tennessee.

What You May Do

If you purchased shares of Rayonier and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit http://ksfcounsel.com/cases/nyse-ryam/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by October 16, 2017 .

About the Lawsuit

Rayonier and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

Since 2013, despite statements by the Company to the contrary, Rayonier had been experiencing ongoing difficulties with one of its top customers, Eastman Chemical Company (“Eastman”), regarding competitive pricing levels and certain terms of the contract between the companies.  Finally, on August 19, 2015, Rayonier revealed the extent of the protracted dispute with Eastman, including that it had filed suit against it the prior week.

On this news, the price of Rayonier shares plummeted 44% to close at $7.62 on extremely heavy trading volume.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com .

Contact:

Kahn Swick & Foti, LLC

Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 1-877-515-1850 206 Covington St. Madisonville, LA 70447

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring Murphy Oil Inc.'s Price-to-Earnings Insights

Updated Category News Views 152

Understanding Murphy Oil Inc.'s Recent Market Performance Currently, Murphy Oil Inc. (NYSE: MUR) shares are valued at $30.88, exhibiting a minor rise of 0.06% in today's trading session. Observing the stock’s journey over the last month, we've seen a significant increase of 6.77%. However, when we take a closer look at the past year, the stock has unfortunately dropped...

Continue Reading
Marco Pharma: 35 Years of Principle Over Profits

Updated Category News Views 3

Keeping Principles Alive in a Competitive Market In an industry where folks often chase the latest trend like seagulls after a fish fry, Marco Pharma International stands its ground on principles rather than profits. It's rare to see a company, especially in the natural health sector, keeping its roots this deep for 35 years. And they're not just talking about it—this...

Continue Reading
Rakovina Therapeutics Unveils AI-Enhanced ATR Inhibitors Breakthrough

Updated Category News Views 188

Rakovina Therapeutics Presents AI-Developed ATR Inhibitors Rakovina Therapeutics Inc. (TSXV: RKV) has made a significant impact at a recent international conference dedicated to cancer therapeutics. The conference gathered numerous leaders in the field, creating an excellent platform to unveil groundbreaking research. Presenting their innovative findings, Rakovina...

Continue Reading
Elon Musk Critiques FCC's Denial of Starlink Subsidy While Aiding Disaster Recovery

Updated Category News Views 334

Elon Musk Critiques FCC's Decision on Starlink Subsidy Elon Musk, the visionary CEO of SpaceX, has voiced his discontent over the FCC's recent ruling that denied approximately $885 million in subsidies to Starlink, the company's satellite internet service. Musk described this decision as "contemptible political lawfare," coinciding with FEMA's deployment of Starlink...

Continue Reading
Assessing the Resilience of American Consumers Amid Challenges

Updated Category News Views 130

Understanding the Current Landscape of American Consumers The state of the American consumer remains resilient despite facing numerous challenges, as reported by Barclays in its recent analysis. The approach to consumer spending in the latest quarter reflects a balancing act, with buyers maneuvering through both advantageous conditions and potential obstacles. Positive...

Continue Reading